Gyogyszerkutato Intezet Kft.

Klara Sutka

Ferenc Andrasi

Lajos Toldy

Katalin Goldschmidt

Laszlo Sebestyen

Zsuzsanna Fittler

Istvan Sziraki

Valeria Vitkoczi

Eszter Hodula

Antal Simay

Peter Matyus

Lajos Farkas

Eva Gal

Agnes Papp

Erzsebet Zara

Ildiko Mathe

Marta Rusz

Zoltan Zubovics

Jozsef Gyimesi

Katalin Szilagyi

Katalin Gorgenyi

An N-benzoylamino acid compound of the formula (I), ##STR1## wherein R.sup.3 is an NR.sup.4 R.sup.5 group where R.sup.4 and R.sup.5 which are the same or different are selected from the group consisting of hydrogen, a hydroxyl group, a C.sub.1-12 alkyl group, a C.sub.1-4 alkyl group substituted by a hydroxyl group and a C.sub.1-4 alkyl group substituted by an amino group;

N-benzoylamino acid derivatives, pharmaceutical compositions containing

The invention relates to novel N-benzoylamino acid derivatives of the general formula (I), ##STR1## wherein R.sup.1 and R.sup.2, which are the same or different, stand for a hydroxyl group optionally bearing an acetyl group; or a C.sub.1-6 alkoxy group optionally substituted by a phenyl group;

N-benzoyl amino acid derivatives pharmaceutical compositions containing

This invention relates to novel compounds of the general formula (I) and the pharmaceutically acceptable acid addition salts thereof. In the general formula (I) ##STR1## wherein Lip, A.sup.1, A.sup.2, Het and n are defined as in the specification. The compounds of the general formula (I) inhibit the lipid peroxidation and therefore, they are useful for the treatment or prevention of diseases and conditions wherein the inhibition of lipid peroxidation is desirable.

Piperazine and homopiperazine derivatives, pharmaceutical compositions

Growing community of inventors

Budapest, Hungary

Klara Sutka